Common stock, .001 par value 200,000,000 shares authorized 14,007,159 and 13,897,503 shares issued and 13,886,826 and 13,777,170 shares outstanding at april 30, 2026 and 2025, respectively
14
Treasury stock, at cost
708
Additional paid-in capital
85,700
Accumulated deficit
-81,067
Total stockholders equity attributable to champions oncology, inc
3,939
Noncontrolling interest
129
Total stockholders' equity
4,068
Total liabilities and stockholders' equity
26,989
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Time Plot
Show the time plot by selecting a row from the table.